In this study we investigated the expression of IDO-1 in two different cohorts of surgically-resected specimens of NSCLC, both in tumor cells and in tumor immune infiltrate, with specific correlation analyses of IDO-1 expression levels and clinical features of patients. Here, IDO1 is linked to neoplasm.